The Axtria Collective | May 2025 Edition
Axtria - Ingenious Insights
Better health outcomes with AI, Digital Transformation, and Omnichannel.
Hello!
Welcome to The Axtria Collective!
This edition features Axtria's 2025 Customer Engagement Planning and Execution Benchmarking Study, a podcast episode on serving rare disease patients with zero functional silos, insights on how agentic AI is making healthcare more personalized and proactive, key takeaways from ISPOR 2025, and an on-demand webinar on harnessing AI/ML for enhanced pharma forecasting.
Happy reading!
⭐Featured Content
2025 Customer Engagement Planning and Execution Benchmarking Study
Omnichannel engagement and AI are reshaping how pharma companies connect with customers. Field reps need dynamic tools and real-time guidance to deliver personalized experiences across all touchpoints. Axtria’s latest benchmarking study reveals how life sciences companies in the US are advancing commercial operations, from customer engagement planning, segmentation and targeting, to omnichannel engagement and field execution.
🎙️Knowledge Stream
Serving Rare Disease Patients with Zero Functional Silos
In this episode of the Leading Minds podcast, Johanna Rossell, SVP and GM Rare Disease at Sumitomo Pharma America, Inc., discusses rare disease treatment and regenerative medicine. Tune in to learn how breaking traditional silos across the healthcare ecosystem, including the FDA, providers, and researchers, is critical for delivering life-changing therapies to patients on time.
🎯Leaders’ Perspective
The Next Wave of Healthcare Will Be More Personalized and Proactive
In this article, Navdeep Chadha, Chief Technology Officer at Axtria, discusses how agentic AI is transforming life sciences through autonomous task execution and dynamic decision-making. He highlights how Axtria's InsightsMAx.ai platform addresses industry challenges while delivering measurable impact across the pharmaceutical value chain.
💡Timeless Insights
ISPOR 2025 Decoded: Axtria’s Must-See Insights and Emerging Themes
This year’s annual ISPOR conference discussed the current limitations of Generative AI while highlighting its vast potential. This comprehensive analysis explores key themes from the conference, including emerging RWE data platforms, causal inference methodologies, and the growing influence of Health Technology Assessments in shaping healthcare decision-making across global markets.
▶️On-demand Webinar
Harnessing AI/ML for Enhanced Pharma Forecasting
Watch this on-demand webinar to explore how AI/ML enhances pharmaceutical forecasting. Learn how AI/ML improves accuracy, automates processes, and detects market trends early. Discover Axtria’s proven strategies and next-gen ML techniques like demand sensing and disease progression modeling for better decision-making.
📰News Capsule
Axtria and Genloop Deliver Domain-Trained LLMs: Advancing Agentic AI in Life Sciences with Enhanced Accuracy, Flexibility, and Cost Efficiency
Axtria partners with GenLoop to deliver fine-tuned LLMs built explicitly for the life sciences. This exclusive collaboration enhances Axtria InsightsMAx.ai with AI models that understand life sciences and pharma terminology, regulatory requirements, and specialized workflows—bridging the gap between generic AI and models that meet pharma's unique needs.
